» Articles » PMID: 8033112

Tumor-forming Ability in Athymic Nude Mice of Human Cell Lines Devoid of Mitochondrial DNA

Overview
Journal Cancer Res
Specialty Oncology
Date 1994 Jul 15
PMID 8033112
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

We have examined the contribution of the mitochondrial genome to the tumorigenic phenotype expressed by human cell lines derived from an ovarian and a cervical carcinoma and from an osteogenic sarcoma. All these continuous cell lines are anchorage-independent in soft agar and form tumors in athymic nude mice. Long-term exposure of the cells to ethidium bromide, an intercalating agent which inhibits mitochondrial DNA replication, gave rise to subclones depleted of mitochondrial DNA and RNA molecules and displaying either anchorage independence or dependence. These respiratory-deficient subclones contain disorganized and enlarged mitochondria, are auxotrophic for uridine and pyruvate, and grow in vitro at a rate nearly identical or moderately slower than their respective parent. The tumor-forming ability of both anchorage-independent and -dependent cell lines was tested by s.c. and intramuscular implantation of the cells in nude mice. We found that the tumorigenic capacity was influenced by the route of inoculation. Subcutaneously, mitochondrial DNA-less cell lines are either poorly or nontumorigenic, while all but one cell line form tumors when implanted into the hind leg muscle. The relative in vivo growth rate of the parent and the mitochondrial DNA-less subclones reflects their respective in vitro rate of growth. All intramuscular tumors introduced into culture mimic the molecular and phenotypic traits of the injected cells, with the exception of the anchorage-dependent cell lines which give rise to anchorage-independent tumor cell lines. The present observations indicate that human cells without mitochondrial DNA have the capacity to proliferate and form tumors in vivo.

Citing Articles

Construction of a novel lipid drop-mitochondria-associated genetic profile for predicting the survival and prognosis of lung adenocarcinoma.

Cai R, Lin H, Cheng Q, Mao Q, Zhang C, Tan Y Discov Oncol. 2024; 15(1):668.

PMID: 39551861 PMC: 11570572. DOI: 10.1007/s12672-024-01526-8.


The role of mitochondria in tumor metastasis and advances in mitochondria-targeted cancer therapy.

Chen F, Xue Y, Zhang W, Zhou H, Zhou Z, Chen T Cancer Metastasis Rev. 2024; 43(4):1419-1443.

PMID: 39307891 PMC: 11554835. DOI: 10.1007/s10555-024-10211-9.


Targeting metabolism to enhance immunotherapy within tumor microenvironment.

Liang X, Chen X, Yan Y, Cheng A, Lin J, Jiang Y Acta Pharmacol Sin. 2024; 45(10):2011-2022.

PMID: 38811773 PMC: 11420344. DOI: 10.1038/s41401-024-01304-w.


Spatial mapping of mitochondrial networks and bioenergetics in lung cancer.

Han M, Bushong E, Segawa M, Tiard A, Wong A, Brady M Nature. 2023; 615(7953):712-719.

PMID: 36922590 PMC: 10033418. DOI: 10.1038/s41586-023-05793-3.


Cancer metabolism and tumor microenvironment: fostering each other?.

Yuan Y, Li H, Pu W, Chen L, Guo D, Jiang H Sci China Life Sci. 2021; 65(2):236-279.

PMID: 34846643 DOI: 10.1007/s11427-021-1999-2.